Search research articles
Contact Us
Filters
Showing results (21-30 of 97) with videos related to
Page
of 10
Sort By:
Pharmaceutical Research
|
December 10, 2003
Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes
Yu-feng Zhang, Ruben J Boado, William M Pardridge
Molecular Pharmaceutics
|
December 20, 2008
Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology
Chun-Fang Xia, Ruben J Boado, William M Pardridge
Bioconjugate Chemistry
|
May 26, 2012
Imaging amyloid plaque in Alzheimer's disease brain with a biotinylated Aβ peptide radiopharmaceutical conjugated to an IgG-avidin fusion protein
Rachita K Sumbria, Ruben J Boado, William M Pardridge
Molecular & Cellular Proteomics : MCP
|
July 4, 2002
Vascular proteomics and subtractive antibody expression cloning
Eric V Shusta, Ruben J Boado, William M Pardridge
Pediatric Research
|
February 7, 2004
Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein
Ruben J Boado, Jian Yi Li, William M Pardridge
Journal of Drug Targeting
|
August 1, 2012
Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies
Qing-Hui Zhou, Ruben J Boado, William M Pardridge
Biotechnology and Bioengineering
|
August 29, 2006
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier
Ruben J Boado, Yufeng Zhang, Yun Zhang, et al.
Biotechnology and Bioengineering
|
October 23, 2008
Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse
Ruben J Boado, Yun Zhang, Yuntao Wang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 15, 2018
Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I
William M Pardridge, Ruben J Boado, Roberto Giugliani, et al.
Molecular Pharmaceutics
|
July 24, 2009
Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier
Eric Ka-Wai Hui, Ruben J Boado, William M Pardridge
Page
of 10
Search research articles
Search
Showing results (21-30 of 97) with videos related to
Sort By:
Page
of 10
Pharmaceutical Research
|
December 10, 2003
Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes
Yu-feng Zhang, Ruben J Boado, William M Pardridge
Molecular Pharmaceutics
|
December 20, 2008
Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology
Chun-Fang Xia, Ruben J Boado, William M Pardridge
Bioconjugate Chemistry
|
May 26, 2012
Imaging amyloid plaque in Alzheimer's disease brain with a biotinylated Aβ peptide radiopharmaceutical conjugated to an IgG-avidin fusion protein
Rachita K Sumbria, Ruben J Boado, William M Pardridge
Molecular & Cellular Proteomics : MCP
|
July 4, 2002
Vascular proteomics and subtractive antibody expression cloning
Eric V Shusta, Ruben J Boado, William M Pardridge
Pediatric Research
|
February 7, 2004
Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein
Ruben J Boado, Jian Yi Li, William M Pardridge
Journal of Drug Targeting
|
August 1, 2012
Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies
Qing-Hui Zhou, Ruben J Boado, William M Pardridge
Biotechnology and Bioengineering
|
August 29, 2006
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier
Ruben J Boado, Yufeng Zhang, Yun Zhang, et al.
Biotechnology and Bioengineering
|
October 23, 2008
Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse
Ruben J Boado, Yun Zhang, Yuntao Wang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 15, 2018
Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I
William M Pardridge, Ruben J Boado, Roberto Giugliani, et al.
Molecular Pharmaceutics
|
July 24, 2009
Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier
Eric Ka-Wai Hui, Ruben J Boado, William M Pardridge
Page
of 10